Hypertension(12%), AST increase(5%), proteinuria(4%), PLT decreased(2%), fatigue(2%), ALT increase(2%), infusion-related reaction(2%), pneumonia(1%), gastrointestinal hemorrhage(1%), liver injury(1%), decreased appetite(1%), diarrhea(1%). This evidence concerns the gene GPT and hypertensive disorder.